Grupo de Neurobioloxia Molecular e Celular da Enfermidade de Parkinson
Parkinson neurobiol
![Foto de Grupo de Neurobioloxia Molecular e Celular da Enfermidade de Parkinson](/img/grupo.png)
![Foto de Centro de Investigación Médica Aplicada](/img/noimage_org.png)
Centro de Investigación Médica Aplicada
Pamplona, EspañaPublicacións en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (33)
2023
-
A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease
Parkinsonism and Related Disorders, Vol. 110
-
Boolean analysis shows a high proportion of dopamine D2 receptors interacting with adenosine A2A receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease
Neurobiology of Disease, Vol. 188
-
Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates
Brain : a journal of neurology, Vol. 146, Núm. 12, pp. 5000-5014
2021
-
An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria
Redox Biology, Vol. 46
-
Glucocerebrosidase gene therapy induces alpha-synuclein clearance and neuroprotection of midbrain dopaminergic neurons in mice and macaques
International Journal of Molecular Sciences, Vol. 22, Núm. 9
2018
-
Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death
Neurotherapeutics, Vol. 15, Núm. 4, pp. 1063-1081
-
Gene therapy approaches in the non-human primate model of Parkinson’s disease
Journal of Neural Transmission, Vol. 125, Núm. 3, pp. 575-589
-
Glucocerebrosidase expression patterns in the non-human primate brain
Brain Structure and Function, Vol. 223, Núm. 1, pp. 343-355
-
Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans
Molecular Neurobiology, Vol. 55, Núm. 7, pp. 5847-5867
-
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia
Brain, Behavior, and Immunity, Vol. 67, pp. 139-151
-
Usefulness of identifying g-protein-coupled receptor dimers for diagnosis and therapy of neurodegenerative diseases and of gliomas
Histology and Histopathology, Vol. 33, Núm. 9, pp. 909-917
2017
-
Brain renin-angiotensin system and microglial polarization: Implications for aging and neurodegeneration
Frontiers in Aging Neuroscience, Vol. 9, Núm. MAY
-
Expression of angiotensinogen and receptors for angiotensin and prorenin in the rat and monkey striatal neurons and glial cells
Brain Structure and Function, Vol. 222, Núm. 6, pp. 2559-2571
-
Neurochemical evidence supporting dopamine D1–D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation
Brain Structure and Function, Vol. 222, Núm. 4, pp. 1767-1784
2016
-
Hints on the Lateralization of Dopamine Binding to D
1
Receptors in Rat Striatum
Molecular Neurobiology, Vol. 53, Núm. 8, pp. 5436-5445
-
Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration
Cell Death and Disease, Vol. 7, Núm. 10
2015
-
Critical period for dopaminergic neuroprotection by hormonal replacement in menopausal rats
Neurobiology of Aging, Vol. 36, Núm. 2, pp. 1194-1208
-
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism
Brain Structure and Function, Vol. 220, Núm. 5, pp. 2721-2738
-
Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum
Biochemical Pharmacology, Vol. 96, Núm. 2, pp. 131-142
-
Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia
Molecular Neurobiology, Vol. 52, Núm. 3, pp. 1408-1420